BACAX | VENAX | BACAX / VENAX | |
Total Expense Ratio | 1.32 | 0.09 | 1,467% |
Annual Report Gross Expense Ratio | 1.36 | 0.09 | 1,511% |
Fund Existence | 20 years | 21 years | - |
Gain YTD | 5.800 | 0.921 | 630% |
Front Load | 5% | N/A | - |
Min. Initial Investment | 1000 | 100000 | 1% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 278M | 8.11B | 3% |
Annual Yield % from dividends | 2.20 | 3.27 | 67% |
Returns for 1 year | -0.80 | -4.70 | 17% |
Returns for 3 years | 29.27 | 21.52 | 136% |
Returns for 5 years | 143.95 | 146.88 | 98% |
Returns for 10 years | 44.94 | 17.86 | 252% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FIKGX | 101.84 | 1.01 | +1.00% |
Fidelity Advisor Semiconductors Z | |||
BSPPX | 733.66 | 6.17 | +0.85% |
iShares S&P 500 Index Investor P | |||
PYVLX | 16.88 | 0.12 | +0.72% |
Payden Equity Income | |||
LFVAX | 26.18 | 0.13 | +0.50% |
Lord Abbett Focused Small Cap Value A | |||
VSGEX | 7.73 | 0.01 | +0.13% |
Virtus SGA International Growth C |